Supplemental and additional funding opportunities exist for SBIR/STTR awardees. The National Institutes of Health has several such opportunities.
Below are some NIH opportunities you can consider for additional and alternative funding:
- I-Corps: The NIH continues to fund the I-Corps program under FOA PA-19-029.This provides up to $55,000 in funding that includes an 8-week hands on training program to help commercialize NIH funded technologies.The program is specifically designed to build entrepreneurial skills and confidence in the business model and validate key commercial hypotheses to improve the likelihood of commercialization. Applications DUE NOVEMBER 19th
- Post-Phase II support: Phase IIB funds are available as continuation of Phase II funding for projects that require more time and effort than typical. Projects funded can be for drugs, vaccines, medical devices or implants as well as other projects that require more substantial research funding.The awards can be up to $1million a year for 3 years.
- Diversity: Funds are available to help promote diversity in R&D. These programs provide administrative supplement funds to small businesses for recruiting and supporting students, postdoctorates, and others from groups that are underrepresented in health-related research. Funding can range from $5000 to more than $100,000.Two such programs are PA-18-837 and PA-18-906
- Technical assistance funding: The Niche Assessment allows applicants access to Foresight Inc. resources for providing market data. The 9-month CAP program provides expertise and industry connections managed through Larta inc. Both programs provide these services at no cost to the selected SBIR companies. Choose not to participate in Niche or CAP? You can request additional Niche Assessment or CAP funds on their SBIR application budget. These funds will be increased in 2019 to $6500 for Phase I companies and $50,000 for Phase II companies.
As always, contact CTC with questions about these opportunities or for help with your applications!